Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS)

Historical Holders from Q3 2018 to Q1 2025

Symbol: GRTS on Nasdaq
Type / Class: Equity / Common Stock, $0.0001 par value per share
Shares outstanding: 160,529,963
All holders as of 31 Mar 2025: Q1 2025
Total 13F shares, excl. options: 0
Holdings value: $0
Number of holders: 0
Number of sells: -2
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
Redmile Group, LLC	8.2%		$131,635		13,163,457		Redmile Group, LLC	31 Dec 2024

Institutional Holders of Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q1	0	$0	-$773				0
2024 Q4	68,866	$773	-$20,647,950	$0	$0	$0.012	2
2024 Q3	35,628,372	$20,661,928	-$4,308,184	$76,612	$229,325	$0.5799	55
2024 Q2	39,212,556	$24,236,603	-$19,716,392	$103,952	$903,244	$0.6179	75
2024 Q1	46,863,208	$120,418,820	+$12,687,383	$11,618,970	$2,212,513	$2.57	84
2023 Q4	42,085,723	$85,856,544	-$11,439,635	$212,160	$255,408	$2.04	88
2023 Q3	48,612,900	$83,617,044	-$4,320,891	$99,072	$153,596	$1.72	88
2023 Q2	50,962,397	$99,490,547	+$7,005,623	$65,910	$145,665	$1.95	86
2023 Q1	46,273,450	$128,634,074	+$4,987,326	$234,910	$359,732	$2.78	89
2022 Q4	44,081,544	$152,081,792	+$37,336,995	$150,765	$340,860	$3.45	89
2022 Q3	33,453,341	$85,974,736	-$4,329,965	$217,000	$348,000	$2.57	76
2022 Q2	35,170,357	$85,107,364	-$17,400,543	$299,000	$256,000	$2.42	81
2022 Q1	39,953,370	$164,926,021	-$163,393,442	$1,555,000	$797,000	$4.12	112
2021 Q4	49,079,808	$629,881,488	+$66,066,934	$5,042,000	$7,405,000	$12.86	112
2021 Q3	42,395,927	$458,360,639	+$86,031,471	$7,369,000	$3,649,000	$10.8	90
2021 Q2	34,818,530	$317,890,500	+$6,996,481	$558,000	$531,000	$9.13	99
2021 Q1	34,045,816	$321,066,530	+$42,420,523	$189,000	$383,000	$9.43	96
2020 Q4	31,980,460	$126,010,396	+$37,330,969			$3.94	67
2020 Q3	22,817,492	$60,471,300	-$31,865,053			$2.65	64
2020 Q2	29,186,352	$193,788,948	-$4,335,520			$6.64	79
2020 Q1	29,847,520	$173,782,820	+$3,188,518			$5.82	64
2019 Q4	26,131,590	$234,363,395	+$5,808,914			$8.97	55
2019 Q3	28,600,546	$246,958,867	-$1,661,860			$8.64	61
2019 Q2	28,735,810	$319,969,665	+$114,720,746			$11.14	62
2019 Q1	18,365,380	$244,257,932	+$2,566,754			$13.3	52
2018 Q4	18,138,333	$278,950,649	+$62,505,876			$15.45	51
2018 Q3	11,087,129	$156,944,000	+$156,936,999			$14.24	43